HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alzheimer's and Danish dementia peptides induce cataract and perturb retinal architecture in rats.

Abstract
Familial Danish dementias (FDDs) are autosomal dominant neurodegenerative disorders that are associated with visual defects. In some aspects, FDD is similar to Alzheimer's disease (AD)- the amyloid deposits in FDD and AD are made of short peptides: amyloid β (Aβ) in AD and ADan in FDD. Previously, we demonstrated an interaction between the dementia peptides and α-crystallin leading to lens opacification in organ culture due to impaired chaperone activity of α-crystallin. Herein, we report the in vivo effects of ADan and Aβ on the eye. ADan [reduced (ADan-red) and oxidized (ADan-oxi)] and Aβ (Aβ1-40 and Aβ1-42) were injected intravitreally in rats. The onset of cataract was seen after injection of all the peptides, but the cataract matured by 2 weeks in the case of ADan-red, 5 weeks for ADan-oxi and 6 weeks for Aβ1-40, while Aβ1-42 had minimal effect on cataract progression. The severity of cataract is associated with insolubilization and alterations in crystallins and loss of chaperone activity of α-crystallin. Further, disruption of the architecture of the retina was evident from a loss of rhodopsin, increased gliosis, and the thinning of the retina. These results provide a basis for the dominant heredo-otoophthalmo-encephalopathy (HOOE)/FDD syndrome and indicate that ADan peptides are more potent than Aβpeptides in inflicting visual impairment.
AuthorsG Bhanuprakash Reddy, P Yadagiri Reddy, Avadhesha Surolia
JournalBiomolecular concepts (Biomol Concepts) Vol. 8 Issue 1 Pg. 45-84 (Mar 01 2017) ISSN: 1868-503X [Electronic] Germany
PMID28222009 (Publication Type: Journal Article, Retracted Publication)
Chemical References
  • Amyloid beta-Peptides
  • Rhodopsin
Topics
  • Alzheimer Disease (metabolism)
  • Amyloid beta-Peptides (toxicity)
  • Animals
  • Cataract (chemically induced, metabolism, pathology)
  • Cerebellar Ataxia (metabolism)
  • Deafness (metabolism)
  • Dementia (metabolism)
  • Gliosis (metabolism)
  • Male
  • Rats
  • Retina (drug effects, metabolism, pathology)
  • Rhodopsin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: